

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.01640911 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.01640911 |
| 3 | actin-myosin filament sliding (GO:0033275) | 5.88464931 |
| 4 | muscle filament sliding (GO:0030049) | 5.88464931 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.83521204 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.83394788 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.83394788 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.76303430 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.27708869 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26109697 |
| 11 | lysine metabolic process (GO:0006553) | 5.05431472 |
| 12 | lysine catabolic process (GO:0006554) | 5.05431472 |
| 13 | actin-mediated cell contraction (GO:0070252) | 4.99974919 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.96943749 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 4.95886844 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87133865 |
| 17 | urea cycle (GO:0000050) | 4.86267852 |
| 18 | urea metabolic process (GO:0019627) | 4.86267852 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.77567458 |
| 20 | cysteine metabolic process (GO:0006534) | 4.75935889 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.75920224 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.73934376 |
| 23 | protein carboxylation (GO:0018214) | 4.73934376 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.73205905 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 4.70502168 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.70502168 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.70502168 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.54817562 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.50611136 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.46595203 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.46308157 |
| 32 | tryptophan metabolic process (GO:0006568) | 4.46024139 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.38425002 |
| 34 | plasma lipoprotein particle clearance (GO:0034381) | 4.34617200 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.33140630 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.33085828 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.31272421 |
| 38 | phospholipid efflux (GO:0033700) | 4.29383268 |
| 39 | triglyceride homeostasis (GO:0070328) | 4.29165287 |
| 40 | acylglycerol homeostasis (GO:0055090) | 4.29165287 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.28713943 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.23821595 |
| 43 | skeletal muscle contraction (GO:0003009) | 4.22249200 |
| 44 | regulation of skeletal muscle contraction (GO:0014819) | 4.19151546 |
| 45 | bile acid metabolic process (GO:0008206) | 4.18748082 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15165473 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.15165473 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.15165473 |
| 49 | regulation of complement activation (GO:0030449) | 4.12534536 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 4.10913382 |
| 51 | phospholipid homeostasis (GO:0055091) | 4.07499434 |
| 52 | actin filament-based movement (GO:0030048) | 4.04827356 |
| 53 | regulation of fibrinolysis (GO:0051917) | 4.04436196 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.03135451 |
| 55 | fatty acid transmembrane transport (GO:1902001) | 4.03081014 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.99874422 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.99874422 |
| 58 | homocysteine metabolic process (GO:0050667) | 3.98665019 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96069665 |
| 60 | tyrosine metabolic process (GO:0006570) | 3.93875508 |
| 61 | positive regulation of lipid catabolic process (GO:0050996) | 3.91772423 |
| 62 | short-chain fatty acid metabolic process (GO:0046459) | 3.90997211 |
| 63 | fatty acid oxidation (GO:0019395) | 3.90573469 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.90017595 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 3.89549159 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.88523770 |
| 67 | plasma lipoprotein particle assembly (GO:0034377) | 3.88045466 |
| 68 | coenzyme catabolic process (GO:0009109) | 3.87995552 |
| 69 | cholesterol efflux (GO:0033344) | 3.87578661 |
| 70 | aspartate family amino acid catabolic process (GO:0009068) | 3.87535444 |
| 71 | ethanol oxidation (GO:0006069) | 3.87532921 |
| 72 | fatty acid catabolic process (GO:0009062) | 3.86039670 |
| 73 | acetyl-CoA metabolic process (GO:0006084) | 3.85321576 |
| 74 | carnitine metabolic process (GO:0009437) | 3.84196612 |
| 75 | lipid oxidation (GO:0034440) | 3.83861021 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83246418 |
| 77 | carnitine shuttle (GO:0006853) | 3.76388042 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.73872329 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69922381 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69922381 |
| 81 | monocarboxylic acid catabolic process (GO:0072329) | 3.68987468 |
| 82 | flavonoid metabolic process (GO:0009812) | 3.67582983 |
| 83 | myofibril assembly (GO:0030239) | 3.63155093 |
| 84 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63038213 |
| 85 | glutamate metabolic process (GO:0006536) | 3.61802331 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.61482978 |
| 87 | cellular amino acid catabolic process (GO:0009063) | 3.61001041 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58782914 |
| 89 | ketone body metabolic process (GO:1902224) | 3.57999942 |
| 90 | protein-lipid complex assembly (GO:0065005) | 3.57395301 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56291778 |
| 92 | cellular glucuronidation (GO:0052695) | 3.56170014 |
| 93 | striated muscle contraction (GO:0006941) | 3.55027577 |
| 94 | sterol homeostasis (GO:0055092) | 3.54945436 |
| 95 | creatine metabolic process (GO:0006600) | 3.54270085 |
| 96 | regulation of relaxation of muscle (GO:1901077) | 3.53843237 |
| 97 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.50795529 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.49520900 |
| 99 | drug catabolic process (GO:0042737) | 3.49399296 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.49018810 |
| 101 | cofactor catabolic process (GO:0051187) | 3.47578671 |
| 102 | organic acid catabolic process (GO:0016054) | 3.46403662 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.46403662 |
| 104 | glycine metabolic process (GO:0006544) | 3.45068901 |
| 105 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.44283952 |
| 106 | indolalkylamine metabolic process (GO:0006586) | 3.44184950 |
| 107 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.44149974 |
| 108 | drug transmembrane transport (GO:0006855) | 3.42080045 |
| 109 | sarcomere organization (GO:0045214) | 3.41700120 |
| 110 | skeletal muscle adaptation (GO:0043501) | 3.40756290 |
| 111 | positive regulation of fatty acid oxidation (GO:0046321) | 3.39203357 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 3.38685677 |
| 113 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.35109040 |
| 114 | valine metabolic process (GO:0006573) | 3.34967860 |
| 115 | arginine metabolic process (GO:0006525) | 3.34832753 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.33432688 |
| 117 | response to inactivity (GO:0014854) | 3.27718088 |
| 118 | response to muscle activity (GO:0014850) | 3.11475439 |
| 119 | cardiac muscle contraction (GO:0060048) | 3.10007988 |
| 120 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.07444489 |
| 121 | plasma membrane repair (GO:0001778) | 3.06159004 |
| 122 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.96432954 |
| 123 | NADH metabolic process (GO:0006734) | 2.89277752 |
| 124 | muscle contraction (GO:0006936) | 2.88628921 |
| 125 | regulation of cell communication by electrical coupling (GO:0010649) | 2.87610684 |
| 126 | cardiac myofibril assembly (GO:0055003) | 2.82975351 |
| 127 | actomyosin structure organization (GO:0031032) | 2.80008832 |
| 128 | cellular response to epinephrine stimulus (GO:0071872) | 2.75279455 |
| 129 | skeletal muscle fiber development (GO:0048741) | 2.68715481 |
| 130 | regulation of necroptotic process (GO:0060544) | 2.67668096 |
| 131 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.63679426 |
| 132 | regulation of actin filament-based movement (GO:1903115) | 2.61843743 |
| 133 | muscle system process (GO:0003012) | 2.59338694 |
| 134 | striated muscle atrophy (GO:0014891) | 2.57525743 |
| 135 | negative regulation of necroptotic process (GO:0060546) | 2.56035783 |
| 136 | response to epinephrine (GO:0071871) | 2.53649531 |
| 137 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.52108033 |
| 138 | glycogen catabolic process (GO:0005980) | 2.52038964 |
| 139 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.46020470 |
| 140 | glucan catabolic process (GO:0009251) | 2.45522555 |
| 141 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.44956291 |
| 142 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.42028633 |
| 143 | skeletal muscle tissue development (GO:0007519) | 2.38072360 |
| 144 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.35303260 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.35303260 |
| 146 | myotube cell development (GO:0014904) | 2.35030102 |
| 147 | cellular polysaccharide catabolic process (GO:0044247) | 2.33229964 |
| 148 | fructose metabolic process (GO:0006000) | 2.32867406 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32123199 |
| 150 | striated muscle adaptation (GO:0014888) | 2.31349323 |
| 151 | barbed-end actin filament capping (GO:0051016) | 2.28906857 |
| 152 | positive regulation of myotube differentiation (GO:0010831) | 2.28213488 |
| 153 | adhesion of symbiont to host cell (GO:0044650) | 2.23644650 |
| 154 | virion attachment to host cell (GO:0019062) | 2.23644650 |
| 155 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.23611876 |
| 156 | cardiac muscle hypertrophy (GO:0003300) | 2.23180867 |
| 157 | regulation of striated muscle contraction (GO:0006942) | 2.23131973 |
| 158 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.21949661 |
| 159 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.21949661 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.20260687 |
| 161 | heart contraction (GO:0060047) | 2.18697452 |
| 162 | heart process (GO:0003015) | 2.18697452 |
| 163 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.17849867 |
| 164 | regulation of the force of heart contraction (GO:0002026) | 2.14729819 |
| 165 | polysaccharide catabolic process (GO:0000272) | 2.12659221 |
| 166 | striated muscle hypertrophy (GO:0014897) | 2.12296001 |
| 167 | glucan biosynthetic process (GO:0009250) | 2.12045779 |
| 168 | glycogen biosynthetic process (GO:0005978) | 2.12045779 |
| 169 | muscle atrophy (GO:0014889) | 2.08919525 |
| 170 | regulation of sequestering of triglyceride (GO:0010889) | 2.08748487 |
| 171 | muscle cell cellular homeostasis (GO:0046716) | 2.08315626 |
| 172 | negative regulation of necrotic cell death (GO:0060547) | 2.08283950 |
| 173 | response to activity (GO:0014823) | 2.07310390 |
| 174 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.05654104 |
| 175 | regulation of necrotic cell death (GO:0010939) | 2.04735730 |
| 176 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.03495409 |
| 177 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.03413328 |
| 178 | muscle fiber development (GO:0048747) | 2.01960111 |
| 179 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.01931285 |
| 180 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.01931285 |
| 181 | protein localization to endosome (GO:0036010) | 2.01262621 |
| 182 | muscle adaptation (GO:0043500) | 1.99600420 |
| 183 | cell adhesion mediated by integrin (GO:0033627) | 1.98565605 |
| 184 | negative regulation of protein localization to cell surface (GO:2000009) | 1.96820789 |
| 185 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 1.95699042 |
| 186 | muscle hypertrophy (GO:0014896) | 1.94540979 |
| 187 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.94437915 |
| 188 | muscle tissue morphogenesis (GO:0060415) | 1.93353515 |
| 189 | cellular response to type I interferon (GO:0071357) | 1.92412337 |
| 190 | type I interferon signaling pathway (GO:0060337) | 1.92412337 |
| 191 | adhesion of symbiont to host (GO:0044406) | 1.91207927 |
| 192 | response to type I interferon (GO:0034340) | 1.91080404 |
| 193 | cardiac muscle tissue morphogenesis (GO:0055008) | 1.90312800 |
| 194 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 1.89867638 |
| 195 | actin filament depolymerization (GO:0030042) | 1.88678271 |
| 196 | glycogen metabolic process (GO:0005977) | 1.88015593 |
| 197 | skin morphogenesis (GO:0043589) | 1.87644174 |
| 198 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 1.87242937 |
| 199 | regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 1.87035278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.15685977 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.32239367 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.92531363 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76451033 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.48374427 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76959021 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91817069 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.69581098 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.90974490 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87047780 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.69646056 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57775408 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36472239 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13107385 |
| 15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0828619 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99161934 |
| 17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95883602 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91385367 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77755795 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71594342 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67428044 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66111585 |
| 23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64457209 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50198691 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49308358 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47501621 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47465656 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45410921 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40563486 |
| 30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39637191 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36612330 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34698752 |
| 33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30684791 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30683142 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30189559 |
| 36 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28306053 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23517088 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21066725 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15687189 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14791575 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14125449 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12284660 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11994934 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11282346 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10943412 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10465533 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10064015 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09734578 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09560386 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09545817 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08040066 |
| 52 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07776045 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06889113 |
| 54 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06599018 |
| 55 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06136911 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06123347 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05726516 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05726516 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02872862 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02310849 |
| 61 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01719964 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01094041 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00290542 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00166224 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99081719 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97485567 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97219847 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96615966 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94263798 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94101051 |
| 71 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93971750 |
| 72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93663549 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93439857 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93368574 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92289719 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92224147 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91146185 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90495791 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89876694 |
| 80 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89153991 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87917710 |
| 82 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87666327 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87405158 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87028150 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86273628 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86244719 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85648297 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85203842 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84911538 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84911538 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84646023 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84586322 |
| 93 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84351483 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84120391 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83931062 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83854347 |
| 97 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82639665 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81927300 |
| 99 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80509658 |
| 100 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80387506 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80354278 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80227653 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78740817 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78737677 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78007978 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77924291 |
| 107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77438289 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77399875 |
| 109 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.77093129 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76941484 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76688480 |
| 112 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.75691656 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75426918 |
| 114 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.75081799 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74936529 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.74777710 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74755455 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72949275 |
| 119 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72648410 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70503522 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68391578 |
| 122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67348487 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66833223 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.66389293 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66103014 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65903607 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65431405 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65082031 |
| 129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.64969391 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64469873 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.64227371 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64044659 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63416426 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62910471 |
| 135 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62762790 |
| 136 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62621097 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61816391 |
| 138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61678638 |
| 139 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61433150 |
| 140 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61072796 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60853801 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59338906 |
| 143 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58766692 |
| 144 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58752362 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58398102 |
| 146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58398102 |
| 147 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57960361 |
| 148 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57820294 |
| 149 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.56965354 |
| 150 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56796044 |
| 151 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56446551 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.56103309 |
| 153 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55817897 |
| 154 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55341754 |
| 155 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55336659 |
| 156 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54301356 |
| 157 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.53579345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.35914835 |
| 2 | MP0005360_urolithiasis | 6.48877458 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.48842039 |
| 4 | MP0005365_abnormal_bile_salt | 5.13034580 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.18861247 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08329782 |
| 7 | MP0003252_abnormal_bile_duct | 3.52802665 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.38488685 |
| 9 | MP0009840_abnormal_foam_cell | 3.35448048 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.32936020 |
| 11 | MP0004510_myositis | 2.79776552 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.64937234 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.49736348 |
| 14 | MP0005083_abnormal_biliary_tract | 2.48620989 |
| 15 | MP0005332_abnormal_amino_acid | 2.34334021 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.23829345 |
| 17 | MP0003195_calcinosis | 2.22280620 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.21401811 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.17256762 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.16398162 |
| 21 | MP0000609_abnormal_liver_physiology | 2.11952280 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.09650981 |
| 23 | MP0005670_abnormal_white_adipose | 2.06103798 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.05054155 |
| 25 | MP0003646_muscle_fatigue | 2.01631745 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.94095005 |
| 27 | MP0004130_abnormal_muscle_cell | 1.88724825 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.79932877 |
| 29 | MP0005369_muscle_phenotype | 1.79176258 |
| 30 | MP0003011_delayed_dark_adaptation | 1.72861829 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.72476934 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.66854558 |
| 33 | MP0001764_abnormal_homeostasis | 1.66038388 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.65111879 |
| 35 | MP0001958_emphysema | 1.60210585 |
| 36 | MP0003303_peritoneal_inflammation | 1.58552208 |
| 37 | MP0003045_fibrosis | 1.55749832 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54787480 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.47484328 |
| 40 | MP0003279_aneurysm | 1.46647539 |
| 41 | MP0003868_abnormal_feces_composition | 1.45212388 |
| 42 | MP0004233_abnormal_muscle_weight | 1.44693850 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.43662524 |
| 44 | MP0004484_altered_response_of | 1.41092257 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.39832070 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.38765456 |
| 47 | MP0004270_analgesia | 1.38743451 |
| 48 | MP0005275_abnormal_skin_tensile | 1.38476052 |
| 49 | MP0000733_abnormal_muscle_development | 1.37628074 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.35762029 |
| 51 | MP0003091_abnormal_cell_migration | 1.28731343 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.27656162 |
| 53 | MP0003186_abnormal_redox_activity | 1.27198679 |
| 54 | MP0003879_abnormal_hair_cell | 1.25897439 |
| 55 | MP0006082_CNS_inflammation | 1.24392766 |
| 56 | MP0004147_increased_porphyrin_level | 1.23037453 |
| 57 | MP0003828_pulmonary_edema | 1.20696011 |
| 58 | MP0002971_abnormal_brown_adipose | 1.19976251 |
| 59 | MP0005166_decreased_susceptibility_to | 1.13075019 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.12557405 |
| 61 | MP0008260_abnormal_autophagy | 1.10935019 |
| 62 | MP0005330_cardiomyopathy | 1.09810716 |
| 63 | MP0003075_altered_response_to | 1.08142450 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.07703446 |
| 65 | MP0009785_altered_susceptibility_to | 1.07520555 |
| 66 | MP0009697_abnormal_copulation | 1.06347441 |
| 67 | MP0000598_abnormal_liver_morphology | 1.05261348 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.05258849 |
| 69 | MP0002108_abnormal_muscle_morphology | 1.04362201 |
| 70 | MP0001542_abnormal_bone_strength | 1.03759710 |
| 71 | MP0002269_muscular_atrophy | 1.03521851 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.01930902 |
| 73 | MP0000751_myopathy | 0.98153879 |
| 74 | MP0009764_decreased_sensitivity_to | 0.97613518 |
| 75 | MP0005451_abnormal_body_composition | 0.97452466 |
| 76 | MP0003436_decreased_susceptibility_to | 0.97079944 |
| 77 | MP0000604_amyloidosis | 0.96206460 |
| 78 | MP0000749_muscle_degeneration | 0.95349994 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.95297731 |
| 80 | MP0005165_increased_susceptibility_to | 0.94415212 |
| 81 | MP0005266_abnormal_metabolism | 0.94146514 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.93879388 |
| 83 | MP0004272_abnormal_basement_membrane | 0.93700198 |
| 84 | MP0009763_increased_sensitivity_to | 0.92640744 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.91647493 |
| 86 | MP0005334_abnormal_fat_pad | 0.91301632 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.90466707 |
| 88 | MP0008874_decreased_physiological_sensi | 0.89207784 |
| 89 | MP0001533_abnormal_skeleton_physiology | 0.88847626 |
| 90 | MP0008469_abnormal_protein_level | 0.87892539 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.87247305 |
| 92 | MP0004087_abnormal_muscle_fiber | 0.86837280 |
| 93 | MP0005023_abnormal_wound_healing | 0.86704367 |
| 94 | MP0001790_abnormal_immune_system | 0.84881861 |
| 95 | MP0005387_immune_system_phenotype | 0.84881861 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.84773887 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 0.84707769 |
| 98 | MP0000685_abnormal_immune_system | 0.84550445 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.84037684 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.83072377 |
| 101 | MP0005647_abnormal_sex_gland | 0.82045746 |
| 102 | MP0005535_abnormal_body_temperature | 0.81850081 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.81845822 |
| 104 | MP0005164_abnormal_response_to | 0.80908115 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.80540063 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.80451426 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.78931742 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.78780188 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.78254520 |
| 110 | MP0000249_abnormal_blood_vessel | 0.75816147 |
| 111 | MP0000920_abnormal_myelination | 0.75324289 |
| 112 | MP0005448_abnormal_energy_balance | 0.74198623 |
| 113 | MP0004947_skin_inflammation | 0.73179402 |
| 114 | MP0002933_joint_inflammation | 0.71885153 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71612999 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.71465496 |
| 117 | MP0001544_abnormal_cardiovascular_syste | 0.71465496 |
| 118 | MP0009115_abnormal_fat_cell | 0.70932287 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.69747753 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.69234939 |
| 121 | MP0010630_abnormal_cardiac_muscle | 0.68275857 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.67728945 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.67284923 |
| 124 | MP0002972_abnormal_cardiac_muscle | 0.66076704 |
| 125 | MP0005025_abnormal_response_to | 0.65402024 |
| 126 | MP0005410_abnormal_fertilization | 0.65046711 |
| 127 | MP0002822_catalepsy | 0.62576578 |
| 128 | MP0002254_reproductive_system_inflammat | 0.60171657 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.59793054 |
| 130 | MP0006138_congestive_heart_failure | 0.59715844 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.58785021 |
| 132 | MP0000747_muscle_weakness | 0.56697331 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.56554675 |
| 134 | MP0004043_abnormal_pH_regulation | 0.55159556 |
| 135 | MP0002970_abnormal_white_adipose | 0.54945288 |
| 136 | MP0001853_heart_inflammation | 0.54054250 |
| 137 | MP0001756_abnormal_urination | 0.53944696 |
| 138 | MP0003724_increased_susceptibility_to | 0.53742192 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.53584286 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.53495018 |
| 141 | MP0003690_abnormal_glial_cell | 0.53441541 |
| 142 | MP0005408_hypopigmentation | 0.53343821 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.53058154 |
| 144 | MP0001661_extended_life_span | 0.52640667 |
| 145 | MP0000343_altered_response_to | 0.49211650 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.48882215 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.48849596 |
| 148 | MP0008961_abnormal_basal_metabolism | 0.48769664 |
| 149 | MP0003329_amyloid_beta_deposits | 0.48567028 |
| 150 | MP0002876_abnormal_thyroid_physiology | 0.48258010 |
| 151 | MP0001324_abnormal_eye_pigmentation | 0.46841844 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.43861545 |
| 153 | MP0002090_abnormal_vision | 0.43836391 |
| 154 | MP0003953_abnormal_hormone_level | 0.43267635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.65327651 |
| 2 | Nemaline bodies (HP:0003798) | 7.63744211 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.43366620 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.66472583 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.41436500 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.62807191 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.50172871 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.50024383 |
| 9 | Xanthomatosis (HP:0000991) | 5.34436417 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.25152317 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.73927072 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.53743302 |
| 13 | Hyperammonemia (HP:0001987) | 4.40296157 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.37981181 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.36066338 |
| 16 | Ketosis (HP:0001946) | 4.21879583 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.14580135 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.13187091 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.10535732 |
| 20 | Complement deficiency (HP:0004431) | 4.10092976 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99094972 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.98162425 |
| 23 | Myopathic facies (HP:0002058) | 3.89024266 |
| 24 | Epidermoid cyst (HP:0200040) | 3.88442768 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.88232538 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.86305674 |
| 27 | Hyperglycinuria (HP:0003108) | 3.83639886 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82126626 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.75974784 |
| 30 | Distal arthrogryposis (HP:0005684) | 3.72280746 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.71115656 |
| 32 | Increased connective tissue (HP:0009025) | 3.68823267 |
| 33 | Neck muscle weakness (HP:0000467) | 3.62794182 |
| 34 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.62769496 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.61397741 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.61397741 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.61003369 |
| 38 | Hyperglycinemia (HP:0002154) | 3.54846080 |
| 39 | Round ear (HP:0100830) | 3.52631708 |
| 40 | Calf muscle hypertrophy (HP:0008981) | 3.51421638 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.50230818 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 3.46670731 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.46599194 |
| 44 | Hypercholesterolemia (HP:0003124) | 3.46480236 |
| 45 | Acanthocytosis (HP:0001927) | 3.44126558 |
| 46 | Ketoacidosis (HP:0001993) | 3.43235711 |
| 47 | Fat malabsorption (HP:0002630) | 3.43069216 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.40026996 |
| 49 | Joint hemorrhage (HP:0005261) | 3.38701703 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 3.36462679 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 3.34905947 |
| 52 | Difficulty running (HP:0009046) | 3.29816016 |
| 53 | Myoglobinuria (HP:0002913) | 3.28494272 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 3.25181971 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.20792750 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.09768193 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 3.09768193 |
| 58 | Frequent falls (HP:0002359) | 3.09688230 |
| 59 | Cholelithiasis (HP:0001081) | 3.07394412 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 3.06465989 |
| 61 | Cholecystitis (HP:0001082) | 3.06465989 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.96724335 |
| 63 | Bundle branch block (HP:0011710) | 2.94857304 |
| 64 | Abnormality of complement system (HP:0005339) | 2.91713364 |
| 65 | Poikilocytosis (HP:0004447) | 2.90716323 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.90643576 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.90225997 |
| 68 | Metabolic acidosis (HP:0001942) | 2.88417714 |
| 69 | Rimmed vacuoles (HP:0003805) | 2.77118828 |
| 70 | Subaortic stenosis (HP:0001682) | 2.77027030 |
| 71 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.77027030 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.76191106 |
| 73 | Skin nodule (HP:0200036) | 2.73360471 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.72638174 |
| 75 | Rhabdomyolysis (HP:0003201) | 2.71271358 |
| 76 | Slender build (HP:0001533) | 2.68961934 |
| 77 | Polycythemia (HP:0001901) | 2.68068239 |
| 78 | Muscle stiffness (HP:0003552) | 2.67813666 |
| 79 | Myocardial infarction (HP:0001658) | 2.66506429 |
| 80 | Spinal rigidity (HP:0003306) | 2.62933557 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.62409446 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56813739 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53830486 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.52338859 |
| 85 | Reticulocytosis (HP:0001923) | 2.50677933 |
| 86 | Lethargy (HP:0001254) | 2.50252468 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.50089278 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.48782250 |
| 89 | Cerebral edema (HP:0002181) | 2.47190733 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.43288670 |
| 91 | Pigmentary retinal degeneration (HP:0001146) | 2.41770274 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.36135017 |
| 93 | EMG: neuropathic changes (HP:0003445) | 2.35550168 |
| 94 | Steatorrhea (HP:0002570) | 2.35212151 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32886093 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.32810188 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.32810188 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.31437611 |
| 99 | Difficulty climbing stairs (HP:0003551) | 2.29542834 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.24973117 |
| 101 | Right ventricular cardiomyopathy (HP:0011663) | 2.22685677 |
| 102 | Nausea (HP:0002018) | 2.22048206 |
| 103 | Scapular winging (HP:0003691) | 2.20956700 |
| 104 | Delayed CNS myelination (HP:0002188) | 2.20755270 |
| 105 | Generalized aminoaciduria (HP:0002909) | 2.20329693 |
| 106 | Malnutrition (HP:0004395) | 2.19499751 |
| 107 | Late onset (HP:0003584) | 2.18362117 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 2.16732089 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.16258696 |
| 110 | Foot dorsiflexor weakness (HP:0009027) | 2.16255114 |
| 111 | Myotonia (HP:0002486) | 2.15986480 |
| 112 | Vomiting (HP:0002013) | 2.15843181 |
| 113 | Bulbar palsy (HP:0001283) | 2.15700020 |
| 114 | Aortic aneurysm (HP:0004942) | 2.14508810 |
| 115 | Lower limb amyotrophy (HP:0007210) | 2.14480082 |
| 116 | Calcaneovalgus deformity (HP:0001848) | 2.14332221 |
| 117 | Vascular calcification (HP:0004934) | 2.14290860 |
| 118 | Spontaneous abortion (HP:0005268) | 2.12551931 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 2.11976396 |
| 120 | Lipoatrophy (HP:0100578) | 2.11148962 |
| 121 | Exercise-induced muscle cramps (HP:0003710) | 2.10963501 |
| 122 | Abnormality of the foot musculature (HP:0001436) | 2.10406936 |
| 123 | Vascular tortuosity (HP:0004948) | 2.09365725 |
| 124 | Gout (HP:0001997) | 2.09221584 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08772167 |
| 126 | Absent phalangeal crease (HP:0006109) | 2.08551816 |
| 127 | Abnormal atrioventricular conduction (HP:0005150) | 2.06920370 |
| 128 | Malignant hyperthermia (HP:0002047) | 2.06698223 |
| 129 | Renal cortical cysts (HP:0000803) | 2.06077942 |
| 130 | Brushfield spots (HP:0001088) | 2.05606843 |
| 131 | Hemorrhage of the eye (HP:0011885) | 2.05404356 |
| 132 | Hyporeflexia of lower limbs (HP:0002600) | 2.05014459 |
| 133 | Generalized muscle weakness (HP:0003324) | 2.03968353 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 2.03899515 |
| 135 | Gowers sign (HP:0003391) | 2.03814300 |
| 136 | Hypertriglyceridemia (HP:0002155) | 2.02546632 |
| 137 | Esophageal varix (HP:0002040) | 2.02483743 |
| 138 | Limb-girdle muscle atrophy (HP:0003797) | 2.02170811 |
| 139 | Pancreatitis (HP:0001733) | 2.00156846 |
| 140 | Heart block (HP:0012722) | 1.99996376 |
| 141 | Premature rupture of membranes (HP:0001788) | 1.98429917 |
| 142 | Arterial tortuosity (HP:0005116) | 1.97066384 |
| 143 | Amyloidosis (HP:0011034) | 1.96942855 |
| 144 | Increased serum ferritin (HP:0003281) | 1.95389623 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94329188 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94329188 |
| 147 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94329188 |
| 148 | Fetal akinesia sequence (HP:0001989) | 1.94148946 |
| 149 | Deformed tarsal bones (HP:0008119) | 1.91840971 |
| 150 | Cardiovascular calcification (HP:0011915) | 1.91819563 |
| 151 | Hyperglycemia (HP:0003074) | 1.91354993 |
| 152 | Areflexia of lower limbs (HP:0002522) | 1.91302157 |
| 153 | Neonatal onset (HP:0003623) | 1.90370272 |
| 154 | Sudden death (HP:0001699) | 1.89451823 |
| 155 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88298696 |
| 156 | Glomerulonephritis (HP:0000099) | 1.87676116 |
| 157 | Palpitations (HP:0001962) | 1.87069163 |
| 158 | Increased muscle lipid content (HP:0009058) | 1.86911064 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.85201971 |
| 160 | Abnormal cartilage morphology (HP:0002763) | 1.84079177 |
| 161 | Ventricular tachycardia (HP:0004756) | 1.83436375 |
| 162 | Muscular dystrophy (HP:0003560) | 1.82996724 |
| 163 | Ventricular arrhythmia (HP:0004308) | 1.82212374 |
| 164 | Hyperkalemia (HP:0002153) | 1.81826129 |
| 165 | Neurofibrillary tangles (HP:0002185) | 1.80941698 |
| 166 | Aortic dissection (HP:0002647) | 1.75942771 |
| 167 | Atrophic scars (HP:0001075) | 1.72686917 |
| 168 | Limb-girdle muscle weakness (HP:0003325) | 1.72029432 |
| 169 | Abnormal finger flexion creases (HP:0006143) | 1.71868894 |
| 170 | Atrioventricular block (HP:0001678) | 1.68432593 |
| 171 | Cerebral aneurysm (HP:0004944) | 1.67085031 |
| 172 | Hip contracture (HP:0003273) | 1.66514954 |
| 173 | Peritonitis (HP:0002586) | 1.66103441 |
| 174 | Achilles tendon contracture (HP:0001771) | 1.64630572 |
| 175 | Weak cry (HP:0001612) | 1.64577086 |
| 176 | Vertebral compression fractures (HP:0002953) | 1.63648970 |
| 177 | Axonal loss (HP:0003447) | 1.63400967 |
| 178 | Waddling gait (HP:0002515) | 1.61272592 |
| 179 | Abnormality of the Achilles tendon (HP:0005109) | 1.58248285 |
| 180 | Rapidly progressive (HP:0003678) | 1.57135655 |
| 181 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.55307506 |
| 182 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.55307506 |
| 183 | Fatigable weakness (HP:0003473) | 1.54715420 |
| 184 | Abnormality of the neuromuscular junction (HP:0003398) | 1.54715420 |
| 185 | Facial diplegia (HP:0001349) | 1.51305694 |
| 186 | Proximal amyotrophy (HP:0007126) | 1.45802653 |
| 187 | Aneurysm (HP:0002617) | 1.45224511 |
| 188 | Ventricular fibrillation (HP:0001663) | 1.44772850 |
| 189 | Atrial fibrillation (HP:0005110) | 1.44479468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.80008615 |
| 2 | PDK3 | 3.18299952 |
| 3 | PDK4 | 3.18299952 |
| 4 | TRIB3 | 3.13776302 |
| 5 | SIK1 | 2.92057742 |
| 6 | ERN1 | 2.86178225 |
| 7 | PKN2 | 2.51643355 |
| 8 | TTN | 2.51602018 |
| 9 | TAOK3 | 2.46057248 |
| 10 | FGFR4 | 2.32580144 |
| 11 | PDK2 | 2.17703376 |
| 12 | MST1R | 2.04884442 |
| 13 | INSRR | 1.99855405 |
| 14 | OBSCN | 1.97144449 |
| 15 | LMTK2 | 1.86060765 |
| 16 | PRPF4B | 1.73260100 |
| 17 | PINK1 | 1.72413992 |
| 18 | PHKG2 | 1.57259548 |
| 19 | PHKG1 | 1.57259548 |
| 20 | PTK6 | 1.51686563 |
| 21 | MOS | 1.48368524 |
| 22 | ERBB4 | 1.46936668 |
| 23 | * TBK1 | 1.46374877 |
| 24 | TRPM7 | 1.45949039 |
| 25 | RIPK1 | 1.44725253 |
| 26 | MAP3K7 | 1.43303686 |
| 27 | PRKAA2 | 1.43204672 |
| 28 | FLT3 | 1.41585551 |
| 29 | TAOK2 | 1.39584832 |
| 30 | PIK3CG | 1.39001211 |
| 31 | MARK1 | 1.37878784 |
| 32 | STK3 | 1.35166031 |
| 33 | MAP3K13 | 1.35029983 |
| 34 | TYK2 | 1.30153094 |
| 35 | DDR2 | 1.29876934 |
| 36 | NEK9 | 1.28573905 |
| 37 | MAP2K3 | 1.27417881 |
| 38 | MAPK11 | 1.22853686 |
| 39 | IKBKE | 1.22620126 |
| 40 | MAP2K4 | 1.22031021 |
| 41 | NEK1 | 1.21846410 |
| 42 | LIMK1 | 1.19369243 |
| 43 | CAMK1D | 1.18901548 |
| 44 | CDC42BPA | 1.16914440 |
| 45 | PRKAA1 | 1.16779513 |
| 46 | MAP3K10 | 1.15233820 |
| 47 | MYLK | 1.13419063 |
| 48 | GRK7 | 1.12193664 |
| 49 | PBK | 1.12058793 |
| 50 | STK24 | 1.09369966 |
| 51 | TESK1 | 1.08699001 |
| 52 | FRK | 1.05121356 |
| 53 | PDPK1 | 1.04650739 |
| 54 | ICK | 1.02145245 |
| 55 | GRK6 | 1.00754675 |
| 56 | JAK2 | 1.00477086 |
| 57 | STK38 | 0.99925590 |
| 58 | MAPKAPK3 | 0.99341249 |
| 59 | ZAP70 | 0.95659416 |
| 60 | KSR2 | 0.94450650 |
| 61 | PAK6 | 0.94034351 |
| 62 | IRAK3 | 0.93781144 |
| 63 | PIK3CA | 0.92753830 |
| 64 | JAK1 | 0.92346837 |
| 65 | TIE1 | 0.91755005 |
| 66 | KDR | 0.88866299 |
| 67 | FGFR3 | 0.86997827 |
| 68 | LATS2 | 0.86960519 |
| 69 | LATS1 | 0.85706327 |
| 70 | MAP3K11 | 0.84948444 |
| 71 | ARAF | 0.84561725 |
| 72 | ABL2 | 0.83682630 |
| 73 | DMPK | 0.83608927 |
| 74 | MAP3K3 | 0.82840214 |
| 75 | GRK5 | 0.81481384 |
| 76 | MAPK7 | 0.80404663 |
| 77 | PDK1 | 0.76636355 |
| 78 | ROCK1 | 0.76402540 |
| 79 | PRKACG | 0.76191322 |
| 80 | MAPK12 | 0.75906065 |
| 81 | JAK3 | 0.75905769 |
| 82 | PRKG2 | 0.75831936 |
| 83 | PTK2B | 0.73862209 |
| 84 | NTRK1 | 0.72717103 |
| 85 | MAP3K12 | 0.71501130 |
| 86 | MAP3K5 | 0.69227490 |
| 87 | MATK | 0.67562387 |
| 88 | TAOK1 | 0.65844441 |
| 89 | GRK1 | 0.65839037 |
| 90 | MARK2 | 0.65436967 |
| 91 | EPHA3 | 0.64093430 |
| 92 | EPHB1 | 0.63435467 |
| 93 | MAP3K14 | 0.63393643 |
| 94 | CAMK1G | 0.62130952 |
| 95 | MET | 0.60560523 |
| 96 | CDK6 | 0.60113796 |
| 97 | MTOR | 0.58338290 |
| 98 | PIM2 | 0.58181003 |
| 99 | SGK2 | 0.57553510 |
| 100 | PRKD1 | 0.56837418 |
| 101 | CAMK2D | 0.56711043 |
| 102 | DYRK1B | 0.56516142 |
| 103 | MAPK4 | 0.56308637 |
| 104 | MAP2K1 | 0.53601994 |
| 105 | CAMK2B | 0.53450886 |
| 106 | TXK | 0.51883745 |
| 107 | ERBB2 | 0.51358794 |
| 108 | ROCK2 | 0.50804878 |
| 109 | PRKD2 | 0.50497139 |
| 110 | SIK2 | 0.49767838 |
| 111 | STK4 | 0.49698309 |
| 112 | DAPK3 | 0.49002716 |
| 113 | PDGFRB | 0.48636602 |
| 114 | SGK223 | 0.48374631 |
| 115 | SGK494 | 0.48374631 |
| 116 | MUSK | 0.48264157 |
| 117 | TGFBR2 | 0.47772823 |
| 118 | DAPK2 | 0.47572455 |
| 119 | MAP2K2 | 0.47476893 |
| 120 | CAMK2A | 0.47402953 |
| 121 | PAK3 | 0.47046003 |
| 122 | CSK | 0.46511445 |
| 123 | RIPK4 | 0.46085004 |
| 124 | KSR1 | 0.45965927 |
| 125 | MAP3K2 | 0.45069500 |
| 126 | CAMK2G | 0.44794895 |
| 127 | IKBKB | 0.43738482 |
| 128 | STK38L | 0.42954355 |
| 129 | CAMK4 | 0.42624500 |
| 130 | EPHB2 | 0.42087476 |
| 131 | PKN1 | 0.41477540 |
| 132 | RET | 0.40542285 |
| 133 | GSK3A | 0.40531689 |
| 134 | WNK1 | 0.39085012 |
| 135 | CAMK1 | 0.38846395 |
| 136 | SGK3 | 0.38794715 |
| 137 | CDK4 | 0.38716559 |
| 138 | MAPK15 | 0.37811377 |
| 139 | MAP2K6 | 0.35827821 |
| 140 | WNK4 | 0.35432669 |
| 141 | ZAK | 0.33843198 |
| 142 | PRKCZ | 0.33786182 |
| 143 | PDGFRA | 0.33734546 |
| 144 | MAP3K1 | 0.33580389 |
| 145 | MAP3K6 | 0.33489869 |
| 146 | KIT | 0.33324480 |
| 147 | TTK | 0.32458143 |
| 148 | PTK2 | 0.30901147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73034373 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35513969 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.02839921 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98502253 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86028623 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78402980 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63005358 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.59764730 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58449837 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56137882 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27477479 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.26711005 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24152700 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23897007 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17662683 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01157809 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98668826 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98066330 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97591452 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.96136491 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88582370 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87913057 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73998011 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70184447 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68690431 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.68472166 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66987134 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63001990 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61185102 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.54109300 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53799788 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51213698 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50570613 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46904713 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.41188390 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40944862 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.40934772 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40356970 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38106503 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37342035 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37121417 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36887053 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36879042 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30987137 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30773345 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29506280 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28215097 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27865921 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25964314 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24597464 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20452916 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19834044 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15579607 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12544956 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 1.12157687 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.10976753 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08449836 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08120474 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07210252 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06126854 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05191048 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03804270 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02308682 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02033762 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 1.01826571 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01354383 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.99462214 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99164566 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98937061 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98489465 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95641315 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93964452 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92947198 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91947964 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88713204 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.86940810 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86765678 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84778038 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84615314 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83324181 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82738648 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82424770 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82167330 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78330275 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77992976 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77322313 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77186768 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77015331 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76765144 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75300837 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73393922 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72614639 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.71604023 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71060501 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70091857 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.68921722 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68478418 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67925978 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67597268 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67346731 |
| 101 | Tuberculosis_Homo sapiens_hsa05152 | 0.65929111 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65058849 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64369592 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62657470 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62403870 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62395190 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.61840893 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60929502 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60659755 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.60245760 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.60109519 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59459132 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59144551 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58291686 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57037815 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56497576 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55234502 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.54050788 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52360629 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51752493 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51682457 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.49838962 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49195228 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.49117040 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48520810 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48245363 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47704033 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47495033 |
| 129 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46995011 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46430764 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.45009650 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.44659751 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44204947 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43615654 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.43403080 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42984626 |
| 137 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42359933 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41871668 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39013517 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38820517 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37993541 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36349123 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33271590 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28378806 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21101758 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20626893 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16818275 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.15164309 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09380581 |
| 150 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08347325 |
| 151 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.07444781 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.06975218 |
| 153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.01647700 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00108867 |
| 155 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1370086 |
| 156 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1243643 |
| 157 | Amoebiasis_Homo sapiens_hsa05146 | -0.0979835 |
| 158 | Hepatitis C_Homo sapiens_hsa05160 | -0.0878875 |
| 159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0869928 |
| 160 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0747272 |
| 161 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0704082 |
| 162 | Phototransduction_Homo sapiens_hsa04744 | -0.0652864 |
| 163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0606166 |
| 164 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0335193 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0332832 |
| 166 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0152060 |

